New Tools for Epilepsy Therapy
One third of the epilepsies are refractory to conventional antiepileptic drugs (AEDs) and, therefore, identification of new therapies is highly needed. Here, we briefly describe two approaches, direct cell grafting and gene therapy, that may represent alternatives to conventional drugs for the treat...
Saved in:
Published in: | Frontiers in cellular neuroscience Vol. 12; p. 147 |
---|---|
Main Authors: | , , |
Format: | Journal Article |
Language: | English |
Published: |
Switzerland
Frontiers Research Foundation
29-05-2018
Frontiers Media S.A |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | One third of the epilepsies are refractory to conventional antiepileptic drugs (AEDs) and, therefore, identification of new therapies is highly needed. Here, we briefly describe two approaches, direct cell grafting and gene therapy, that may represent alternatives to conventional drugs for the treatment of focal epilepsies. In addition, we discuss more in detail some new tools, cell based-biodelivery systems (encapsulated cell biodelivery (ECB) devices) and new generation gene therapy vectors, which may help in the progress toward clinical translation. The field is advancing rapidly, and there is optimism that cell and/or gene therapy strategies will soon be ready for testing in drug-resistant epileptic patients. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Reviewed by: Gabriele Losi, Istituto di Neuroscienze (IN), Italy; Alfonso Represa, INSERM U901 Institut de Neurobiologie de la Méditerranée, France Edited by: Marco Ledri, Lund University, Sweden |
ISSN: | 1662-5102 1662-5102 |
DOI: | 10.3389/fncel.2018.00147 |